UCP1 and fatty liver disease: • Lean and resistance to HFD-induced obesity and hepatic steatosis • Increased oxygen consumption • Unaffected adipogenesis, increased certain lipogenic enzymes, and UCP1 in Adipose tissue • Inhibited lipogenesis and enhanced gluconeogenesis